+1 (502) 904-2126   One Westbrook Corporate Center, Suite 300, Westchester, IL 60154, USA   Site Map
ISSN: 2574 -1241

Impact Factor : 0.548

  Submit Manuscript

OpinionOpen Access

The Use of Combined Oral Contraceptives in Women with Multiple Sclerosis

Volume 4 - Issue 4

Tikhonovskaya O and MD Kochetkova A*

  • Author Information Open or Close
    • Siberian State Medical University, Russia

    *Corresponding author:Kochetkova Anastasia, Full Time Postgraduate at the Department of Obstetrics and Gynecology, Siberian State Medical University, Russia

Received: May 07, 2018;   Published: May 17,2018

DOI: 10.26717/BJSTR.2018.04.001082

Full Text PDF

To view the Full Article   Peer-reviewed Article PDF


Multiple sclerosis (MS) is an autoimmune disease of the central nervous system, which is characterized by a progressive increase in neurological symptoms. The prevalence of MS in the world has recently increased. This is due both to a real increase in the incidence rate and to the use of modern neuroimaging methods of research. It can be assumed that sex steroid hormones affect the pathogenesis and course of MS because the prevalence of MS among women is 2 times higher than that of men, and in addition, the disease has gender differences. The predominance of women is particularly high among young patients, as well as in the family group.